New name for Diabetes Insipidus (DI)

Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.

Diabetes Insipidus: a common condition for Histiocytosis and Pituitary conditions

Today’s podcast focuses on an opportunity to learn about a group of rare diseases that share a common condition with pituitary disease. Histiocytosis or histiocytic disorders are a group of rare diseases that occur when there is an overproduction of white blood cells known as histiocytes that can lead to organ damage and tumor formation. DI impacts almost 50% of Histiocytosis patients and 35% of pituitary patients.

Insights on Diabetes Insipidus

This podcast focuses on fluid, electrolyte disorders and hyponatremia in a case of a patient with Diabetes Insipidus (DI).         Photo by Clark  

More on the Diabetes Insipidus Survey

Several months ago we published a survey on Diabetes Insipidus where we asked you to contribute your experiences.  In that survey, among other questions, we asked you what you wanted others to know about Diabetes

Diabetes Insipidus Survey

This is a questionnaire/survey on Diabetes Insipidus. Thank you for participating.  Your responses and insights will be gleaned to write an article for Pituitary World News. Click here to start the Diabetes Insipidus Survey And stay tuned